Welcome to the international HTA database

Showing [21959 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2016	Basque Office for Health Technology Assessment (OSTEBA)	[Economic analysis of peripherally inserted central venous catheters (PICC), inserted by nursing staff, in cancer and hematological patients]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Nivolumab - Addendum to Commission A15-32]
2016	NIHR Health Technology Assessment programme	The use of exploratory analyses within the National Institute for Health and Care Excellence single technology appraisal process: an evaluation and qualitative analysis
2016	NIHR Public Health Research (PHR) programme	Implications for public health research of models and theories of disability: a scoping study and evidence synthesis
2016	Health Quality Ontario (HQO)	Transcatheter aortic valve implantation for treatment of aortic valve stenosis: a health technology assessment
2016	Basque Office for Health Technology Assessment (OSTEBA)	[Interventions to improve CPAP treatment adherence in patients with obstructive sleep apnea]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Pembrolizumab - Addendum to Commission A15-33]
2016	NIHR Health Technology Assessment programme	A randomised controlled trial to measure the effects and costs of a dental caries prevention regime for young children attending primary care dental services: the Northern Ireland Caries Prevention In Practice (NIC-PIP) trial
2016	NIHR Health Technology Assessment programme	Social Stories to alleviate challenging behaviour and social difficulties exhibited by children with autism spectrum disorder in mainstream schools: design of a manualised training toolkit and feasibility study for a cluster randomised controlled trial with nested qualitative and cost-effectiveness components
2016	NIHR Health Technology Assessment programme	Bladder ultrasonography for diagnosing detrusor overactivity: test accuracy study and economic evaluation
2016	NIHR Health Services and Delivery Research programme	Do-not-attempt-cardiopulmonary-resuscitation decisions: an evidence synthesis
2016	NIHR Health Services and Delivery Research programme	The Prevalence of Visual Impairment in People with Dementia (the PrOVIDe study): a cross-sectional study of people aged 60-89 years with dementia and qualitative exploration of individual, carer and professional perspectives
2016	Health Quality Ontario (HQO)	Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: a health technology assessment
2016	Basque Office for Health Technology Assessment (OSTEBA)	[Prenatal screening for Down syndrome through fetal DNA sequencing from maternal blood]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Tiotropium/olodaterol - Addendum to Commission A15-31]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Everolimus (Afinitor) for diffuse large B-cell lymphoma – maintenance therapy
2016	NIHR Health Services and Delivery Research programme	Determining the optimal model for role substitution in NHS dental services in the UK: a mixed-methods study
2016	Health Quality Ontario (HQO)	Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: OHTAC recommendation
2016	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Acute neck and back pain: preventive interventions – Effects of physical training, manual treatment and cognitive behavioral interventions]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Pertuzumab - Addendum to Commission A15-34]
2016	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia: a multicentre randomised controlled trial
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Dabrafenib (Tafinlar) and trametinib (Mekinist) combination therapy for advanced BRAF mutated non-small cell lung cancer
2016	Adelaide Health Technology Assessment (AHTA)	Microwave tissue ablation for primary and secondary liver cancer
2016	Health Quality Ontario (HQO)	Levonorgestrel-releasing intrauterine system (52 mg) for idiopathic heavy menstrual bleeding: OHTAC Recommendation
2016	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Prenatal diagnosis through Next Generation Sequencing (NGS)]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Isavuconazole - Assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	ADI-PEG 20 for hepatocellular carcinoma – second line
2016	Health Quality Ontario (HQO)	Transcatheter aortic valve implantation for treatment of aortic valve stenosis: OHTAC recommendation
2016	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Prenatal diagnosis through Chromosomal Microarray Analysis (CMA)]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Searches in trial registries for studies on newly approved drugs]
2016	NIHR Health Technology Assessment programme	An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Heartcel for heart failure in patients at risk of incomplete revascularisation following coronary artery bypass graft
2016	NIHR Public Health Research (PHR) programme	IMPRoving Outcomes for children exposed to domestic ViolencE (IMPROVE): an evidence synthesis
2016	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Drug treatment of children with respiratory tract infections - a scoping review]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Alirocumab - Benefit assessment according to §35a Social Code Book V]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Furosemide sc2Wear micro-pump patch for oedema in heart failure
2016	NIHR Health Services and Delivery Research programme	Getting the most out of knowledge and innovation transfer agents in health care: a qualitative study
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Exploratory examination of the need for revision of the DMP "coronary heart disease"]
2016	NIHR Health Technology Assessment programme	A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC)
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Pertuzumab (Perjeta) with chemotherapy and trastuzumab for HER2-positive early breast cancer – adjuvant therapy
2016	NIHR Health Services and Delivery Research programme	Location of care for people with serious mental illness (LOCAPE): implications for service use and costs using a mixed-methods approach
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Dabrafenib/trametinib - Addendum to Commissions A15-39 and A15-40]
2016	National Evidence-based Healthcare Collaborating Agency (NECA)	[Study of horizon scanning and potential health impact assessment of emerging health technology and development of operation system of H-SIGHT]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Remestemcel-L for graft vs host disease in paediatric patients – second line
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Models for providing care and services to patients who have concurrent mental health and substance use disorders]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Pomalidomide - Addendum to Commission A15-42]
2017	NIHR Health Technology Assessment programme	A randomised controlled study of the effectiveness of breathing retraining exercises taught by a physiotherapist either by instructional DVD or in face-to-face sessions in the management of asthma in adults
2017	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of surgical options for the management of anterior and/or posterior vaginal wall prolapse: two randomised controlled trials within a comprehensive cohort study results from the PROSPECT Study
2017	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Occupational chemical exposures and cardiovascular disease]
2017	NIHR Health Technology Assessment programme	A multicentre, randomised controlled trial of position during the late stages of labour in nulliparous women with an epidural: clinical effectiveness and an economic evaluation (BUMPES)
2017	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Treatment options of arm fractures in the elderly]
2017	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Interventions to improve foster children’s mental and physical health]
2017	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Endobronchial valves for the treatment of emphysema bullae.
2017	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Barricaid prosthesis for partial annulus replacement
2017	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Endovascular arteriovenous fistula creation systems
2017	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	STAR tumour ablation system
2017	NIHR Health Technology Assessment programme	Effectiveness and cost effectiveness of cognitive behaviour therapy and short-term psychoanalytic psychotherapy compared with brief psychosocial intervention in the maintenance of symptomatic remission in adolescents with unipolar major depression (IMPACT): a randomised controlled trial
2017	NIHR Health Technology Assessment programme	Support and Assessment for Fall Emergency Referrals (SAFER) 2: a cluster randomised trial and systematic review of clinical effectiveness and cost-effectiveness of new protocols for emergency ambulance paramedics to assess older people following a fall with referral to community-based care when appropriate
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Angiogenesis inhibitors (bevacizumab - ranibizumab) in neovascular glaucoma and corneal neovascularization]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Bariatric surgery as treatment for obesity in subjects over 65 years old]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	Bariatric surgery to treat obesity in individuals under 21 years old
2017	HAYES, Inc.	Dorsal root ganglion stimulation for the treatment of complex regional pain syndrome
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Usefulness of N-terminal type B natriuretic propeptide in amyloidosis]
2017	HAYES, Inc.	Flexitouch system (Tactile Systems Technology Inc.) for lymphedema
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Dynamic magnetic resonance imaging in pelvic floor dysfunction]
2017	HAYES, Inc.	Glucagon-like peptide-1 receptor agonists for the treatment of obesity in women with polycystic ovary syndrome
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Reducing mammaplasty for the treatment of patients with breast hypertrophy and chronic dorsalgia]
2017	HAYES, Inc.	iFuse Implant System (SI-Bone Inc.) for sacroiliac joint fusion for treatment of sacroiliac joint dysfunction
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Arterial stiffness measurement for cardiovascular risk classification in high blood pressure patients]
2017	HAYES, Inc.	Gore cardioform septal occluder (W.L. Gore & Associates) for closure of atrial septal defects
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Intrathecal opioid infusion pump for chronic cancer and non-cancer pain]
2017	HAYES, Inc.	Impella 2.5 System (Abiomed Inc.) for cardiac support in patients undergoing high-risk percutaneous coronary intervention
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Nonmydriatic stereoscopic retinal imaging for retinal condition]
2017	HAYES, Inc.	Intravenous immunoglobulin for treatment of intractable epilepsy in pediatric patients
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Transbronchial lung cryobiopsy in diffuse interstitial lung disease diagnosis]
2017	HAYES, Inc.	Ketamine infusion for treatment-resistant bipolar depression
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Cryoablation for the treatment of persistent or symptomatic paroxysmal atrial fibrillation]
2017	HAYES, Inc.	Micra transcatheter pacing system (Medtronic Inc.) for single-chamber pacemaker indications
2017	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	Biofeedback for women with urinary, fecal or combined incontinence
2017	HAYES, Inc.	Ocrelizumab (Ocrevus; Genentech Inc.) for primary progressive and relapsing-remitting multiple sclerosis
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Pomalidomide for relapsed and refractory myeloma]
2017	HAYES, Inc.	Radiofrequency nerve ablation for treatment of plantar fasciitis
2017	NIHR Public Health Research (PHR) programme	Evaluation of the impacts on health of the proposed UK industry levy on sugar sweetened beverages: developing a systems map and data platform, and collection of baseline and early impact data
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Epidermal growth factor (Heberprot-P®) in chronic ulcers]
2017	HAYES, Inc.	Raindrop near vision inlay (ReVision Optics Inc.) for presbyopia
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Biological agents and tofacitinib in rheumatoid arthritis]
2017	HAYES, Inc.	Teduglutide (Gattex; Shire-NPS Pharmaceuticals Inc.) to reduce parenteral support requirements in adults with short bowel syndrome
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Stiripentol for the treatment of severe myoclonic epilepsy in infants (Dravet's syndrome)]
2017	HAYES, Inc.	Urolift system (NeoTract Inc.) for treatment of benign prostatic hyperplasia
2017	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: beta-lactam allergies, assessment of the risk of cross-reactivity with cephalosporins and carbapenems in penicillin-allergic patients]
2017	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Primary section - surgical techniques and reimbursement]
2017	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Cannabinoids in patients with autism spectrum disorders]
2017	HAYES, Inc.	Afirma thyroid FNA analysis (Veracyte)
2017	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: use, in Québec, of probiotics in the prevention of Clostridium difficile-associated diarrhea in hospitalized patients on antibiotic therapy]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Transanal endoscopic microsurgery (tem) and transanal minimally invasive surgery (tamis) for the treatment of rectal lesions]
2017	HAYES, Inc.	AlloSure (CareDx)
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Intensity-modulated radiation therapy for breast cancer]
2017	HAYES, Inc.	Cologuard (Exact Sciences Corp.)